ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $30,552,000 | -12.5% | 408,504 | -26.3% | 0.41% | +51.3% |
| Q2 2020 | $34,905,000 | -99.9% | 554,491 | -16.7% | 0.27% | +1.1% |
| Q1 2020 | $27,122,507,000 | -10.3% | 665,583 | 0.0% | 0.27% | +31.7% |
| Q4 2019 | $30,230,780,000 | +99134.4% | 665,583 | 0.0% | 0.20% | -4.7% |
| Q3 2019 | $30,464,000 | -21.9% | 665,583 | 0.0% | 0.21% | -20.9% |
| Q2 2019 | $39,023,000 | +30.8% | 665,583 | 0.0% | 0.27% | +27.0% |
| Q1 2019 | $29,838,000 | – | 665,583 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |